Where, when and under what conditions clinical trial data are generated may matter
COVARIS helps pharmaceutical and biotech sponsors and CROs make relevant external context visible, comparable and decision-relevant across planned countries, regions, study windows and selected assessment settings
Clinical evidence is generated across countries, regions, seasons and study windows. Increasingly, assessments and data-generating activities also take place in participants’ homes and daily environments.
COVARIS translates environmental, geographic, temporal and setting-related context into practical inputs for clinical trial planning, design, clinical evidence generation and interpretation.
Who we work with
COVARIS works with pharmaceutical and biotech sponsors and CROs on clearly defined clinical trial questions.
Our most established work supports planning for late phase 2 and phase 3 trials across countries, regions and enrollment windows. We also develop selected participant, assessment and disease-relevant context applications together with sponsors.
Why this matters
External conditions can differ across countries, regions, seasons, study windows and participant settings. These conditions are not always neutral in relation to disease activity, exposure adequacy, endpoint measurement or the practical context in which participants complete study activities.
COVARIS helps sponsors distinguish expected real-world heterogeneity from external context that may be excessive, avoidable or important to document before key assumptions about trial footprint, timing and assessments are locked.
Grounded in ICH E5, ICH E17 and ICH E6(R3)
ICH E5 and E17 recognise that regional and extrinsic factors may influence how clinical evidence is generated and interpreted across populations and geographies.
ICH E6(R3) strengthens the focus on quality by design, proportionality and the early identification of factors that may be critical to trial quality.
COVARIS applies this logic to external context by helping sponsors identify, compare and document relevant environmental, geographic, temporal and setting-related conditions where they are scientifically and operationally relevant.
What COVARIS does
COVARIS translates environmental, geographic, temporal and setting-related context into practical inputs for clinical trial planning, design, evidence generation and interpretation.
Our work spans three connected areas:
Trial Footprint Context
Comparison of relevant external context across planned countries, regions and study windows.
Participant and Assessment Context
Context around home-based activities, assessments and selected digital endpoints.
Disease-Relevant Context
Selected environmental factors with a defensible rationale linked to the disease, endpoint or intended use.
Across all three areas, COVARIS combines traceable data, scientific rationale and focused analysis to make external context visible, comparable and decision-relevant.
What to expect
Each COVARIS engagement starts with a clearly defined sponsor question and analytical scope.
Depending on the use case, the delivery may include:
Comparative context analysis
Structured comparison across countries, regions, study windows or selected assessment settings.
Visual outputs
Maps, profiles, dashboards and scenario views that make relevant differences easy to review.
Method and data transparency
Clear documentation of data sources, analytical logic, uncertainty and interpretation.
Decision-focused readout
A concise report and founder-led discussion focused on the questions, assumptions and options most relevant to the sponsor.
How COVARIS works
COVARIS starts with the sponsor’s question, intended use and decision context.
We then define the relevant countries, regions, study windows, assessment settings and external context variables.
The analysis combines traceable data, scientific rationale and comparative methods to identify meaningful differences, patterns and review points.
The result is translated into clear visual outputs, a concise analytical report and a focused discussion of the implications for planning, design, evidence generation or interpretation.
How COVARIS can be applied
COVARIS can support clearly defined questions across trial planning, study timing, regional context and selected assessment settings. Typical applications include:
Trial Country and Regional Context
COVARIS can compare relevant external conditions across planned countries and regions and highlight where deeper regional review may be useful.
Study Window and Scenario Analysis
COVARIS can assess how enrollment periods and study windows interact with seasonal conditions and test constrained planning scenarios.
Participant and Assessment Context
In scoped cases, COVARIS can describe the external context around home-based activities, assessments and selected digital endpoints.
Illustrative cases
Trial Country Baseline Dashboard
A comparative dashboard showing differences in climate, seasonal timing, air pollution, greenness and built-up intensity across a defined set of trial countries.
Global COPD Scenario Analysis
A global COPD case showing how environmental dispersion across a planned trial footprint can be assessed and reduced through constrained adjustments to regional enrollment allocation.
Atopic Dermatitis Humidity Context Analysis
A focused case examining how humidity, temperature and seasonal conditions vary across planned countries, regions and study periods relevant to atopic dermatitis.
Trial-to-Market Context Analysis
An anonymised case comparing the environmental and seasonal context of a global trial footprint with conditions in a European target market relevant to local evidence interpretation and assessment.
Discuss a clinical trial context question
If you are planning a late phase 2 or phase 3 trial, COVARIS can help assess relevant external context across planned countries, regions, enrollment windows and selected assessment settings before key trial assumptions are locked.
COVARIS helps sponsors and CROs make relevant external context visible across trial countries, regions, study windows and selected assessment settings.
COVARIS does not predict outcomes or prove causal effects. It provides external context intelligence for sponsor-led planning, evidence generation and interpretation.
COVARIS ApS
2100 Copenhagen
Denmark
+45 25 30 30 28
CVR-no.: 46484673